After MPs Reject Brexit Deal, UK ABPI Wants Solution 'Quickly'

Following the government’s defeat over the Brexit withdrawal deal, the life sciences industry wants the UK parliament to find a solution quickly to avoid a “no-deal” scenario.

UK_EU
The UK parliament has rejected the Brexit deal • Source: Shutterstock

The Association of the British Pharmaceutical Industry has called on UK parliamentarians to find a solution “quickly” to avoid medicines shortages after parliament overwhelmingly rejected the Brexit deal agreed with the EU in November 2018, casting yet more doubt on the way forward for relations between the UK and the EU after the Brexit date of March 29.

The uncertainty generated by the vote, which took place in the evening of Jan. 15, will be anathema to the...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from United Kingdom

More from Europe

Bayesian Statistics In EU Clinical Trials: EMA Discusses Balancing Efficiency With Rigor

 

Bayesian statistics could help clinical trial sponsors to include external information in their analyses, but concerns around bias and incorrect conclusions remain, the European Medicines Agency said.

European Industry Calls For Support As It Juggles Multiple Challenges

 
• By 

At Medicines for Europe’s legal and annual conferences in Brussels last week, multiple key issues competed for attention, giving the generics and biosimilars industry plenty to think about at a critical time for EU pharma reform.

England’s NHS Plan Eyes Cancer Vaccine Boost, Single Formulary & ‘Pay For Impact’ Drug Deal

 

The creation of a single national formulary for medicines prescribing that could impact industry is among the action points in the UK government’s new 10-year health plan for the National Health Service in England.